Action Potential Stimulation Therapy (APST) is an emerging therapeutic approach that involves the application of electrical stimulation to modulate and restore neural activity. While APST is a relatively new field of research, it holds promise as a potential treatment for multiple sclerosis (MS).
What We Offer
Please contact our Centre Team for more information.
More About APST in relation to MS:
Principles of APST: APST is based on the concept of using electrical stimulation to elicit action potentials in neurons, which are the electrical impulses that facilitate communication between nerve cells. The goal is to modulate neural activity and potentially promote neuroplasticity, which is the brain’s ability to reorganise and form new connections.
Potential Benefits: APST has shown promise in preclinical and early clinical studies for its potential to improve motor function, reduce spasticity and enhance overall neurological recovery in individuals with MS. By stimulating neural pathways, APST aims to promote reorganisation of the central nervous system and facilitate functional recovery.
Techniques and Modalities: Various APST techniques and modalities are being explored for their potential efficacy in MS. These include transcranial direct current stimulation (tDCS), transcranial magnetic stimulation (TMS) and direct cortical stimulation (DCS). These techniques involve the application of electrical currents or magnetic fields to specific regions of the brain or spinal cord to influence neural activity.
Research and Clinical Trials: Research on APST in MS is still in its early stages, and larger, well-designed clinical trials are needed to establish its safety, efficacy, optimal parameters and long-term effects. While initial studies have shown promising results, further research is necessary to determine the specific protocols, patient selection criteria and treatment duration that may provide the most significant benefits.
Complementary Approach: APST is not typically used as a standalone therapy but rather as a complementary approach alongside established MS treatments. It may be integrated into a comprehensive treatment plan that includes disease-modifying therapies, symptomatic management, rehabilitation and other supportive interventions.
It is important to note that APST for MS is still considered an investigational and evolving therapeutic approach. Individuals interested in APST should discuss it with their healthcare professionals, particularly those specialised in MS, who can provide the most up-to-date information, guidance and assess its appropriateness based on individual circumstances.
Contact from individuals or healthcare professionals welcomed.